SCHEMBL7945520

SCHEMBL7945520

COc1ccc2c(c1)NCC2C(=O)C(=O)N(CC(=O)NCCOc1ccccc1)CC1CCCCC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
PKM P14618 1/20 0.39
EPHX2 P34913 1/20 0.39
RECQL P46063 1/20 0.37
MTNR1A P48039 1/20 0.37
MTNR1B P49286 1/20 0.37
POLB P06746 2/20 0.36
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
HPGD P15428 1/20 0.35
ALDH1A1 P00352 2/20 0.35
MAPT P10636 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
PPARD Q03181 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7951892 0.91 POLB (0.39) NPC1RAB9AEPHX2POLBHPGD
SCHEMBL7944071 0.86 HTT (0.40) NPC1RAB9AEPHX2MTNR1AMTNR1B
SCHEMBL7948016 0.85 POLB (0.38) NPC1RAB9ASMN1; SMN2PKMEPHX2
SCHEMBL7969063 0.85 CYP2D6 (0.42) POLBHPGDALDH1A1MAPTNPSR1
SCHEMBL7982206 0.84 POLB (0.36) NPC1RAB9AEPHX2MTNR1AMTNR1B
SCHEMBL7951886 0.84 MITF (0.45) NPC1RAB9ASMN1; SMN2PKMEPHX2
SCHEMBL7946743 0.84 MITF (0.45) NPC1RAB9ASMN1; SMN2PKMEPHX2
SCHEMBL7947094 0.84 POLB (0.37) NPC1RAB9ASMN1; SMN2PKMEPHX2
SCHEMBL7947062 0.84 MITF (0.43) NPC1RAB9ASMN1; SMN2PKMEPHX2
SCHEMBL7937735 0.82 KMT2A (0.41) NPC1SMN1; SMN2MTNR1AMTNR1BPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010035032-A1 CALCIUM ION CHANNEL MODULATORS & USES THEREOF LECTUS THERAPEUTICS LIMITED (GB) 2010-04-01 WO disclosed
WO-2009133387-A1 INDOLE- 3 -GLYOXYLAMIDE DERIVATIVES FOR USE AS CALCIUM ION CHANNEL MODULATORS LECTUS THERAPEUTICS LIMITED (GB) 2009-11-05 WO disclosed